# The Impact of Oral Vitamin C in Prevention for Post Operative Atrial Fibrillation (POAF) in Coronary Artery Bypass Surgery (CABG) Patients

> **NCT06074367** · PHASE4 · UNKNOWN · sponsor: **Helwan University** · enrollment: 180 (actual)

## Conditions studied

- Post Operative Atrial Fibrillation

## Interventions

- **DRUG:** Vitamin C 500 MG Oral Capsule(High dose 2g daily)
- **DRUG:** Vitamin C 500 MG Oral Capsule(Low-dose 1g daily)
- **DRUG:** placebo capsules

## Key facts

- **NCT ID:** NCT06074367
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-13
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-10-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06074367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06074367, "The Impact of Oral Vitamin C in Prevention for Post Operative Atrial Fibrillation (POAF) in Coronary Artery Bypass Surgery (CABG) Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06074367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*